49869 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 20
18:36 UTC
|
EL
Estee Lauder Companies
|
◎ Target | Andrea Teixeira not yet tracked | Overweight | $94.00→ $112.00+19.1% |
|
Aug 20
18:36 UTC
|
EL
Estee Lauder Companies
|
◎ Target | Bonnie Herzog ★★★☆☆ #1592 | Buy | $100.00→ $112.00+12.0% |
|
Aug 20
18:36 UTC
|
EL
Estee Lauder Companies
|
◎ Target | Dara Mohsenian ★★★☆☆ #1122 | Equal Weight | $90.00→ $102.00+13.3% |
|
Aug 20
18:36 UTC
|
CRM
Salesforce
|
◎ Target | Keith Bachman ★★★☆☆ #1153 | Outperform | $215.00→ $230.00+7.0% |
|
Aug 20
18:36 UTC
|
BILL
BILL
|
◎ Target | Daniel Jester ★★★★☆ #951 | Market Perform | $46.00→ $55.00+19.6% |
|
Aug 20
18:36 UTC
|
BILL
BILL
|
◎ Target | Chris Quintero ★★★☆☆ #1879 | Equal Weight | $55.00→ $60.00+9.1% |
|
Aug 20
18:36 UTC
|
BILL
BILL
|
◎ Target | Will Nance ★★★☆☆ #1332 | Buy | $50.00→ $57.00+14.0% |
|
Aug 20
18:36 UTC
|
ADI
Analog Devices
|
◎ Target | Joseph Moore ★★★☆☆ #1823 | Overweight | $428.00→ $458.00+7.0% |
|
Aug 20
18:36 UTC
|
ADI
Analog Devices
|
◎ Target | Harlan Sur ★★★☆☆ #1354 | Overweight | $450.00→ $500.00+11.1% |
|
Aug 20
18:36 UTC
|
ACDC
ProFrac
|
◎ Target | Joe Laetsch ★★★☆☆ #2107 | Underweight | $5.00→ $4.50-10.0% |
|
Aug 20
18:36 UTC
|
MRK
Merck & Co., Inc.
|
↓ Downgrade | Trung Huynh ★★☆☆☆ #2866 | Outperform→ Sector Perform | $142.00→ $150.00+5.6% |
|
Aug 20
17:36 UTC
|
ZM
Zoom Communications
|
◎ Target | Taylor McGinnis ★★★★☆ #513 | Neutral | $105.00→ $115.00+9.5% |
|
Aug 20
17:36 UTC
|
WIX
Wix.com
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Neutral | $55.00→ $80.00+45.5% |
|
Aug 20
17:36 UTC
|
TOL
Toll Brothers
|
◎ Target | Jonathan Bettenhausen ★★★☆☆ #2232 | Buy | $165.00→ $170.00+3.0% |
|
Aug 20
17:36 UTC
|
TOL
Toll Brothers
|
◎ Target | John Lovallo ★★★☆☆ #1073 | Buy | $187.00→ $195.00+4.3% |
|
Aug 20
17:36 UTC
|
TGT
Target
|
◎ Target | Scot Ciccarelli ★★★☆☆ #1589 | Hold | $147.00→ $167.00+13.6% |
|
Aug 20
17:36 UTC
|
TGT
Target
|
◎ Target | Michael Lasser ★★★★☆ #947 | Buy | $166.00→ $185.00+11.4% |
|
Aug 20
17:36 UTC
|
TEAM
Atlassian
|
◎ Target | Joel Fishbein not yet tracked | Buy | $160.00→ $185.00+15.6% |
|
Aug 20
17:36 UTC
|
SNOW
Snowflake
|
◎ Target | Miller Jump ★★★☆☆ #1991 | Buy | $300.00→ $375.00+25.0% |
|
Aug 20
17:36 UTC
|
SJM
J. M. Smucker
|
◎ Target | Peter Grom ★★★☆☆ #1618 | Buy | $130.00→ $142.00+9.2% |
|
Aug 20
17:36 UTC
|
PD
PagerDuty
|
◎ Target | Joel Fishbein not yet tracked | Buy | $11.00→ $13.00+18.2% |
|
Aug 20
17:36 UTC
|
NU
NU
|
◎ Target | Thiago Batista ★★★☆☆ #1203 | Buy | $16.90→ $18.20+7.7% |
|
Aug 20
17:36 UTC
|
MRNA
Moderna
|
◎ Target | Eliana Merle ★★★☆☆ #1995 | Neutral | $50.00→ $150.00+200.0% |
|
Aug 20
17:36 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Evan David Seigerman not yet tracked | Outperform | $142.00→ $170.00+19.7% |
|
Aug 20
17:36 UTC
|
MRCY
Mercury Systems
|
◎ Target | Alexandra Mandery not yet tracked | Buy | $109.00→ $120.00+10.1% |
|
Aug 20
17:36 UTC
|
MDB
MongoDB
|
◎ Target | Miller Jump ★★★☆☆ #1991 | Buy | $400.00→ $475.00+18.8% |
|
Aug 20
17:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Scot Ciccarelli ★★★☆☆ #1589 | Buy | $255.00→ $254.00-0.4% |
|
Aug 20
17:36 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Timothy Chiodo ★★★★☆ #952 | Neutral | $165.00→ $170.00+3.0% |
|
Aug 20
17:36 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | David Dai ★★★★☆ #457 | Neutral | $4.00→ $7.00+75.0% |
|
Aug 20
17:36 UTC
|
GTLB
GitLab
|
◎ Target | Miller Jump ★★★☆☆ #1991 | Hold | $30.00→ $40.00+33.3% |
|
Aug 20
17:36 UTC
|
EXPE
Expedia Group
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Outperform | $334.00→ $417.00+24.9% |
|
Aug 20
17:36 UTC
|
ESTC
Elastic
|
◎ Target | Miller Jump ★★★☆☆ #1991 | Buy | $80.00→ $100.00+25.0% |
|
Aug 20
17:36 UTC
|
EBAY
eBay
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Outperform | $135.00→ $137.00+1.5% |
|
Aug 20
17:36 UTC
|
DUOL
Duolingo
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Neutral | $139.00→ $150.00+7.9% |
|
Aug 20
17:36 UTC
|
DASH
DoorDash
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Neutral | $205.00→ $220.00+7.3% |
|
Aug 20
17:36 UTC
|
CRTO
Criteo
|
◎ Target | Ygal Arounian ★★☆☆☆ #2753 | Outperform | $30.00→ $25.00-16.7% |
|
Aug 20
17:36 UTC
|
BILL
BILL
|
◎ Target | Sanjay Sakhrani ★★★★☆ #655 | Market Perform | $46.00→ $54.00+17.4% |
|
Aug 20
17:36 UTC
|
AMGN
Amgen
|
◎ Target | David Amsellem ★★★☆☆ #1811 | Overweight | $427.00→ $457.00+7.0% |
|
Aug 20
17:36 UTC
|
ABBV
AbbVie
|
◎ Target | David Amsellem ★★★☆☆ #1811 | Overweight | $298.00→ $303.00+1.7% |
|
Aug 20
17:36 UTC
|
DRUG
Bright Minds Biosciences
|
↓ Downgrade | firm only | Market Perform | |
|
Aug 20
16:36 UTC
|
XERS
Xeris Biopharma
|
◎ Target | Glen Santangelo ★★★☆☆ #1452 | Overweight | $9.00→ $12.00+33.3% |
|
Aug 20
16:36 UTC
|
TGT
Target
|
◎ Target | Edward Kelly ★★★☆☆ #1808 | Overweight | $165.00→ $185.00+12.1% |
|
Aug 20
16:36 UTC
|
SBAC
SBA Communications
|
◎ Target | Brendan Lynch ★★★☆☆ #1858 | Overweight | $245.00→ $208.00-15.1% |
|
Aug 20
16:36 UTC
|
S
SentinelOne
|
◎ Target | Saket Kalia ★★★☆☆ #1325 | Equal Weight | $16.00→ $22.00+37.5% |
|
Aug 20
16:36 UTC
|
MRVL
Marvell Technology
|
◎ Target | Timothy Arcuri ★★★☆☆ #2105 | Buy | $300.00→ $310.00+3.3% |
|
Aug 20
16:36 UTC
|
MRT
Marti Technologies
|
◎ Target | Fawne Jiang ★★★★☆ #631 | Buy | $5.00→ $6.00+20.0% |
|
Aug 20
16:36 UTC
|
MRK
Merck & Co., Inc.
|
◎ Target | Michael Yee ★★★☆☆ #1517 | Buy | $145.00→ $175.00+20.7% |
|
Aug 20
16:36 UTC
|
MAR
Marriott International
|
◎ Target | Robin Farley not yet tracked | Neutral | $412.00→ $395.00-4.1% |
|
Aug 20
16:36 UTC
|
LOW
Lowe's Companies
|
◎ Target | Michael Lasser ★★★★☆ #947 | Buy | $285.00→ $275.00-3.5% |
|
Aug 20
16:36 UTC
|
JKHY
Jack Henry & Associates
|
◎ Target | Nik Cremo ★☆☆☆☆ #2917 | Overweight | $170.00→ $185.00+8.8% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.